Palo Alto, CA/ Frankfurt – December 04, 2008 – Evolved Machines, Inc. and Nanostart holding Nanosys Inc. announced that Evolved Machines has entered into a sublicense agreement with Nanosys for a portfolio of patents and patent applications related to the use of nanotubes and nanowires for artificial olfaction and chemical sensing.
Press releases
Nanostart holding NanoGram and Tokyo Electron Ltd. enter thin-film photovoltaics joint development agreement
Frankfurt / Milpitas, CA. – November 13, 2008 – Nanostart Holding NanoGram Corporation has extended its relationship with Tokyo Electron Ltd. (TEL) from strategic investor to technology and market development partner by entering into a joint development agreement (JDA).
Nanogate acquires majority in Nanostart holding Holmenkol
- Nanogate pursing strategic interests with this acquisition
- Holmenkol leads in high-performance, high-tech surfaces for sports products
- “Holmenkol developing superbly”
Frankfurt / Heimerdingen / Göttelborn – November 12, 2008 – Nanogate AG, based in the German state of Saarland, has acquired majority ownership of Holmenkol AG, a Nanostart portfolio company. The aim of the acquisition is to drive forward with the strategic development of the sports and leisure markets within Nanogate AG.
Nanostart holding Namos achieves important milestone
- Proprietary process from Namos reduces precious metal consumption for making automotive catalytic converters by up to 50%
- Successful completion of aging test marks major step toward market introduction
- Test confirms that new technology functions flawlessly at high operating temperatures
Frankfurt / Dresden – October 30, 2008 – The successful completion of an aging test marks a significant step forward for the new catalytic converter technology from Namos GmbH, a Dresden-based company partly owned by Nanostart AG. This new process is anticipated to reduce the consumption of precious metals such as platinum in the production of automotive catalytic converters by up to one half.
Nanostart at NanoEquity Europe 2008
- Nanostart and its portfolio companies to present at Europe’s largest capital markets event
- Nanostart co-organizer of the leading forum for nanotechnology and investment
- NanoEquity Europe as a proven model for success transfer to Asia
Frankfurt, October 22, 2008 - Nanostart AG is serving as co-organizer and sponsor of the fourth annual NanoEquity Europe conference, the leading forum for nanotechnology and the capital markets, to be held in the Frankfurt Congress Center on November 11 and 12. Organized this year by Deutsche Börse in close cooperation with Nanostart, NanoEquity Europe 2008 is for the first time being integrated as a specialized industry forum into the German Equity Forum, which with over 5,000 participants is the largest capital markets event in Europe.
Germany’s ERP Start Fund invests in Nanostart-held Namos
- Investment of up to one million euros from German government program
- Immense precious metal savings in manufacture of catalytic converters
- Unique, proprietary process with high market demand
Frankfurt/Dresden, October 13, 2008 - Namos GmbH, a Dresden-based company which is partly owned by Nanostart AG, will receive up to one million euros from the ERP Start Fund, a joint program of the Kreditanstalt für Wiederaufbau (KfW), the German government-owned development bank, and the German Federal Ministry of Economics and Technology.
Nanostart holding Lumiphore Announces a Partnership to Develop Diagnostic Tests for Drugs of Abuse with Biophor Diagnostics, Inc.
Richmond, CA. / Frankfurt - September 16, 2008 – Nanostart holding Lumiphore, Inc announced that they have signed an exclusive agreement with Biophor Diagnostics, Inc., Redwood City, California.
Under the agreement, Biophor Diagnostics holds the exclusive rights to apply Lumi4 TM technology to current and future diagnostic tests for drugs of abuse. Lumi4TM fluorescent metal-reporter compounds bring excellent fade-resistant photophysical properties, increased sensitivity, stability, and robustness to assays in the drugs of abuse testing market.
Dr. David J. Ecker joins board of directors of Nanostart holding Lumiphore
Richmond, CA / Frankfurt, September 16, 2008 – Nanostart holding Lumiphore announced the appointment of Dr. David J. Ecker to its board of directors. Dr. Ecker is Chief Scientific Officer and a founder of Ibis Biosciences. He is also a co-founder and Vice President of Isis Pharmaceuticals. As the third member of Lumiphore's board, he brings both a general expertise in successful biotech commercialization and a specific expertise in detection and assay platforms.
Page 1 of 4
